CD8A and neoplasm: Specifically, the combination of higher regulatory-like CD8+ Tγδ cells and reduced NK/NKT cytotoxicity reflects a functional decline in the effector arm of immunity, pointing to a mechanistic link between immunosenescence and reduced anti-tumor activity in older patients.